Highlights:
- SPYRAL HTN-OFF MED provides “proof of principle” that renal denervation lowers blood pressure
- Rate of target lesion failure significantly lower with Orsiro than with Xience
- Profile: Francesco Maisano
- Harlan M Krumholz: Good care means ensuring patients are thoroughly informed
[pdfviewer width=”100%” height=”940px” beta=”true”]https://cardiovascularnews.com/wp-content/uploads/sites/14/2017/10/47-Cardiovascular-News-EU.pdf[/pdfviewer]
